The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (LIGHT-2) - Clinical Trial NCTNCT06921486
Business Opportunities for NCT06921486
Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Obesity and Overweight.
Clinical Trial Information
- Study Sponsor
- Sponsor information available
- Drug/Intervention
- Study intervention details available
- Therapeutic Area
- Overweight
- Study Phase
- PHASE2
- Study Status
- RECRUITING
- NCT Number
- NCTNCT06921486
Find Contact Information
Access exclusive contact details for:
- Principal investigators and sub-investigators
- Study coordinators and research staff
- Site directors and facility contacts
- Sponsor representatives and CRO partners
- Business development professionals
- Clinical operations managers
Clinical Trial Locations
This study has 13 locations across China.
Study Site
Guangzhou, China
Study Site
Guangzhusi, China
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships